Under Armour, Inc. Stock 12‑Month Price Target Raised to $6.2, Implies 3% Downside
Analyst estimates for Under Armour, Inc. show the average 12-month price target increased to $6.20 from $6.13, with a range of $4 to $10 per share. Based on the Aug. 6 close, the target implies about 3% downside. The consensus rating remains Hold, with 4 Buys, 19 Holds, and 3 Sells.
How this was made
The 30-second read
Why it matters
Because the consensus remains Hold, the target increase alone is unlikely to drive a major repricing unless it signals a broader wave of upgrades not captured here.
Market read
This is a modest analyst-target update with unchanged consensus, more useful for monitoring sentiment than for making a high-conviction trade.
What to watch
The article does not disclose the underlying thesis for the target change, so traders should treat it as sentiment data rather than a fundamental update.
Background
The piece summarizes FactSet-derived analyst estimates for Under Armour’s 12-month price target and consensus rating.
Ticker impact
Under Armour’s average 12-month price target rose from $6.13 to $6.20, with a $4 to $10 range and consensus still Hold.
Likely small, short-lived sentiment effect; follow-through depends on whether additional analysts upgrade beyond the Hold consensus.
The article provides a specific target update and implied downside, but it also states the consensus rating remains Hold (4 Buys, 19 Holds, 3 Sells), reducing expected repricing magnitude.
Market effects
Limited read-through to apparel/athletic footwear peers because this is a single-name analyst target adjustment without new company fundamentals.
No clear regional spillover beyond US equity sentiment for consumer discretionary/apparel.
Minimal global relevance; no international deal, regulation, or macro shock described.
Counterpoint
A higher average target can still mask dispersion risk, since the range remains wide ($4 to $10) and the consensus rating is unchanged.
Key entities
- equityUnder Armour, Inc.
US-listed apparel company whose average 12-month analyst price target increased to $6.20 while consensus rating stayed Hold.
